Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness

Author:

Hamill Jonathan1,Hallak Jaime1,Dursun Serdar M.1,Baker Glen1

Affiliation:

1. Department of Psychiatry (Neurochemical Research Unit) and Neuroscience & Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada

Abstract

Background: Ayahuasca, a traditional Amazonian decoction with psychoactive properties, is made from bark of the Banisteriopsis caapi vine (containing beta-carboline alkaloids) and leaves of the Psychotria viridis bush (supplying the hallucinogen N,N-dimethyltryptamine, DMT). Originally used by indigenous shamans for the purposes of spirit communication, magical experiences, healing, and religious rituals across several South American countries, ayahuasca has been incorporated into folk medicine and spiritual healing, and several Brazilian churches use it routinely to foster a spiritual experience. More recently, it is being used in Europe and North America, not only for religious or healing reasons, but also for recreation. Objective: To review ayahuasca’s behavioral effects, possible adverse effects, proposed mechanisms of action and potential clinical uses in mental illness. Method: We searched Medline, in English, using the terms ayahuasca, dimethyltryptamine, Banisteriopsis caapi, and Psychotria viridis and reviewed the relevant publications. Results: The following aspects of ayahuasca are summarized: Political and legal factors; acute and chronic psychological effects; electrophysiological studies and imaging; physiological effects; safety and adverse effects; pharmacology; potential psychiatric uses. Conclusion: Many years of shamanic wisdom have indicated potential therapeutic uses for ayahuasca, and several present day studies suggest that it may be useful for treating various psychiatric disorders and addictions. The side effect profile appears to be relatively mild, but more detailed studies need to be done. Several prominent researchers believe that government regulations with regard to ayahuasca should be relaxed so that it could be provided more readily to recognized, credible researchers to conduct comprehensive clinical trials.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology,General Medicine

Reference197 articles.

1. Halpern JH, Sherwood AR, Passie T, Blackwell KC, Ruttenber AJ. Med Sci Monit, Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament.,, 2008, 14,18668010, SR15-SR22,

2. Kjellgren A, Eriksson A, Norlander T. J Psychoactive Drugs, Experiences of encounters with ayahuasca--“the vine of the soul.,, 2009, 41,, 309-315,10.1080/02791072.2009. 10399767

3. Gable RS, , ,, , Risk assessment of ritual use of oral N,Ndimethyltryptamine (DMT) and harmala alkaloids Addiction; M.J, Winkelman; T.B, Roberts, Eds.; Psychedelic Medicine (Vol 2): New evidence for hallucinogenic substances as treatments, 2007, 102, (1), 24-34., , ,-

4. Callaway JC, McKenna DJ, Grob CS, Brito GS, Raymon LP, Poland RE, Andrade EN, Andrade EO, Mash DC. J Ethnopharmacol, Pharmacokinetics of Hoasca alkaloids in healthy humans.,, 1999, 65,, 243-256,10.1016/S0378-8741(98)00168-8

5. Mabit J, , ,, , Ayahuasca in the treatment of addictions. Psychedelic Medicine (Vol 2): New Evidence for Hallucinogenic Substances as Treatments, 2007, 87. M.J, Winkelman; T.B, Roberts Praeger Publishers Westport, CT(105)., , ,-

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3